Gyre Therapeutics
GYRE
GYRE
31 hedge funds and large institutions have $1.04M invested in Gyre Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
31
Holding in Top 10
–
Calls
$44K
Puts
–
Top Buyers
| 1 | +$92.4K | |
| 2 | +$21.4K | |
| 3 | +$9.66K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$8.95K |
| 5 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$4.84K |
Top Sellers
| 1 | -$82K | |
| 2 | -$35.8K | |
| 3 | -$17K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$11.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.33K |